Menu
Recruiting NCT04441983

Foot/Extremities at 7T MRI

— Observational Plantar Plate Tear

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: 7 Tesla MRI of the foot.
Who it may be relevant to
Registry conditions: Plantar Plate Tear. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Switzerland
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

7 TESLA MRI EVALUATION OF THE FOOT AND EXTREMITIES

Overview

* To evaluate standard clinical sequences for 7 Tesla MRI of the foot and extremities to improve detailed depiction of the complex anatomy of this region. * To evaluate various pathologies of the foot and extremities (plantar plate tears, Morton neuroma, tendon tears, ligament tears etc.).

Interventions

  • Diagnostic test 7 Tesla MRI of the foot
    7 Tesla MRI

Primary outcome measures

  • sensitivity / specificity [Time frame: 2 years]

Eligibility criteria

Inclusion criteria

  • Informed consent as documented by signature (Appendix Informed Consent Form)
  • at least 18 years old
  • Study group: Patients with specific pathologies (i.e. Morton neuroma, tendon tears, plantar plate tears) as proven by 1,5 or 3T MRI or asymptomatic subjects (to look at the normal microanatomy of different structures, mainly the plantar plate)
  • Control group: No evidence of the respective pathology.

Exclusion criteria

  • previous foot/ extremities surgery with metal in vivo
  • pregnancy or breast feeding
  • any MRI contra-indications

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

Switzerland · 1 center
  • Balgrist University Hospital — Zurich

Identifiers

NCT: NCT04441983 · R449

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗